• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down1.54% Nasdaq Down1.52%

    Isis Pharmaceuticals, Inc. (ISIS)

    -NasdaqGS
    65.33 Down 0.98(1.48%) Apr 17, 4:00PM EDT
    |After Hours : 65.45 Up 0.12 (0.18%) Apr 17, 7:41PM EDT
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2014Dec 31, 2013Dec 31, 2012
    Total Revenue 214,161   147,285   102,049  
    Cost of Revenue -   -   -  
    Gross Profit 214,161   147,285   102,049  
    Operating Expenses
    Research Development241,751  184,033  158,458  
    Selling General and Administrative20,140  14,918  12,515  
    Non Recurring -   -   -  
    Others -   -   -  
    Total Operating Expenses -   -   -  
    Operating Income or Loss (47,730) (51,666) (68,924)
    Income from Continuing Operations
    Total Other Income/Expenses Net15,548  4,463  16,895  
    Earnings Before Interest And Taxes(32,182)(47,203)(53,435)
    Interest Expense22,209  19,355  21,152  
    Income Before Tax(54,391)(66,558)(74,587)
    Income Tax Expense(15,407)(5,914)(9,109)
    Minority Interest -   -   -  
    Net Income From Continuing Ops(47,276)(60,644)(71,654)
    Non-recurring Events
    Discontinued Operations -   -   -  
    Extraordinary Items -   -   -  
    Effect Of Accounting Changes -   -   -  
    Other Items -   -   -  
    Net Income (38,984) (60,644) (65,478)
    Preferred Stock And Other Adjustments -   -   -  
    Net Income Applicable To Common Shares (38,984) (60,644) (65,478)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.